RxDoctor Payments Data

Joseph Izzo

Internal Medicine · Buffalo, NYNPI 1750481065

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $7,186 of the $7,675 with a category attached, or 93.6%. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,675in general payments, 2019–2025

Across 7 payments — averaging $1096.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Clarus Therapeutics Inc.$4K
  • Boehringer Ingelheim$3K
$1,567,720in research payments, 2019–2025

Across 124 payments — averaging $12,643 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$784K
  • Merck$318K
  • Boehringer Ingelheim$160K
  • Astrazeneca UK Limited$143K
  • Novartis$58K
  • Lexicon Pharmaceuticals, Inc.$36K
  • plus $68K from 5 others

What the payments were for

  • Speaking & faculty fees$7,18694%
  • Travel & lodging$2593%
  • Food & beverage$2313%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Clarus Therapeutics Inc.6$4,490
Boehringer Ingelheim1$3,186

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,675 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan34$21,943
FarxigaDapagliflozin Propanediol11$6,913

Paid to pharmacies, not to this prescriber.

Other internal medicine in Buffalo

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →